The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026).
 
Maeve Hennessy
Employment - Abbvie (I)
Stock and Other Ownership Interests - Abbvie (I)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Aranzazu Fernández
No Relationships to Disclose
 
Chiung Yu Huang
No Relationships to Disclose
 
Ashley Cimino-Mathews
Research Funding - Bristol Myers Squibb Foundation (Inst)
 
Rita Denbow
No Relationships to Disclose
 
Vandana G Abramson
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Guardant Health
Research Funding - Bayer; Guardant Health
 
Mothaffar F. Rimawi
Consulting or Advisory Role - AstraZeneca; Macrogenics; Novartis; Pfizer; Sermonix Pharmaceuticals
 
Jennifer M. Specht
Honoraria - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Sensei Biotherapeutics
Consulting or Advisory Role - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Lyell Immunopharma Inc; Sensei Biotherapeutics; Volastra Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Carisma Therapeutics (Inst); Cascadian Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; GE Healthcare; GlaxoSmithKline; Nektar
 
Anna Maria Storniolo
Employment - Q32 Bio (I)
Leadership - Q32 Bio (I)
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo
 
Vicente Valero
Honoraria - AstraZeneca; Genentech/Roche; Novartis
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Novartis
Travel, Accommodations, Expenses - Genentech/Roche
 
Chris Vaklavas
No Relationships to Disclose
 
Eric P. Winer
Research Funding - Genentech (Inst)
 
Ian E. Krop
Employment - PureTech (I)
Leadership - PureTech (I)
Stock and Other Ownership Interests - PureTech (I)
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Merck; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - anti-murine CD19 monoclonal antibody licensed to PharMingen
 
Antonio C. Wolff
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Richard L. Wahl
Stock and Other Ownership Interests - Clarity Pharmaceuticals
Honoraria - Abdera Thereapeutics; Bristol-Myers Squibb; Jubilant DraxImage; Molecular Targeting Technologies; Radiopharm Theranostics; Seno Medical; Siemens Healthineers; Voximetry
Consulting or Advisory Role - clarity pharmaceuticals
Research Funding - Actinium Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); perspective/viewpoint pharmaceuticals (Inst); RayzeBio (Inst); Siemens Healthineers (Inst); white rabbit AI (Inst)
Travel, Accommodations, Expenses - Actinium Pharmaceuticals; Siemens Healthineers
Other Relationship - society of nuclear medicine
 
E Aubrey Thompson
No Relationships to Disclose
 
Vered Stearns
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); QUE Oncology (Inst)
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine (Inst)
 
Charles Perou
Leadership - GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric; Reveal Genomics
Consulting or Advisory Role - Bioclassifier; GeneCentric; NanoString Technologies; Reveal Genomics; Veracyte
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent
 
Lisa A. Carey
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); NanoString Technologies (Inst); Novartis (Inst); Seagen (Inst); Veracyte (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly; Novartis (Inst); SeaGen
 
Roisin M. Connolly
Consulting or Advisory Role - Astra Zeneca/Daichii; AstraZeneca; Gilead Sciences
Research Funding - AstraZeneca (Inst); Daichii Sankyo (Inst); MSD (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
Other Relationship - Roche
(OPTIONAL) Uncompensated Relationships - AICRI; Astra Zeneca/Daichii (HER2 low obs study); Decrescendo; Develop Med; Seagen